From Our President

ISOQOL Mid-year Wrap-up
By Joanne Greenhalgh, PhD

As we are halfway through 2023, I would like to give you a brief update on current developments at ISOQOL.
[Read More]

   Important Dates

4 September:
ISOQOL office will be closed

5 September:
Live Webinar – Transitioning Between Academia and Industry: A Career Panel
[Read More]

18 September:
2023 Annual Conference Advanced Registration Closes
[Read More]

   Science TALK

Implementing the FDA’s draft guidance on core PROs in cancer trials: the challenge of a modular approach [Read More]

The story behind “The Elephant in the Room”: A long journey begins with a single step [Read More]

Improving the quality of life for people living with chronic conditions: A Population Health Framework [Read More]


Why PROMs in Clinical Practice Matter? An Introduction to the Clinical Practice Special Interest Group [Read More]

Regulatory and Health Technology Assessment Engagement (R&HE) SIG’s Response to FDA Patient-Focused Drug Development Guidance 4 [Read More]

How to Submit an Editorial

Do you have something to share about health related quality of life and patient-centered outcomes? We want to hear from you!

Learn More

Interested in Advertising?

Although ISOQOL does not offer advertising in QualityTALK, we do offer opportunities to advertise in our News Update e-blast.

Learn More

Like what you see?

Please share QualityTALK with anyone you think would be interested.

The International Society for Quality of Life Research (ISOQOL) is a global community of researchers, clinicians, health care professionals, industry professionals, consultants, and patient research partners advancing health related quality of life research (HRQL).

Together, we are creating a future in which patient perspective is integral to health research, care and policy.